An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Article in Nature Medicine (April 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Nature Medicine (April 2024)
Article in Vaccine (March 2024)
Article in Proceedings of the Royal Society B (February 2024)